Belongs to

• Center for Hematologic Malignancies

Types of Work

["2023"]

[[["Meeting Abstracts",543],["Journal Articles",358],["Reviews",36],["Research Letters",20],["Book Sections",10],["Guidelines",10],["Correspondences",6],["Editorials",5],["Conference Papers",1]]]

[989]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• male
• multiple myeloma

Recent Works

1. Barriers to chimeric antigen receptor T-cell therapy

   Research Letter

   Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
   JAMA Oncology (2025)

   Fulltext@MSK | Save
2. Multiple myeloma, version 1.2025 featured updates to the NCCN guidelines®

   Guidelines

   Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D. Jr; Baljevic, M.; Baz, R.; Campagnaro, E.; Costello, C.; D’Angelo, C.; Derman, B.; more...
   Journal of the National Comprehensive Cancer Network (2025)

   Fulltext@MSK | Save
3. Phase 1 clinical trial of B-cell maturation antigen (BCMA) NEX-T® chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma

   Journal Article

   Ravi, G.; Richard, S.; Kumar, S.; Atrash, S.; Liedtke, M.; Kaur, G.; Derman, B.; Bergsagel, P. L.; Mailankody, S.; McCarthy, P.; more...
   Leukemia (2025)

   Fulltext@MSK | Save